A+ Science AB

Metabolon

The dock that “thinks” for itself

The world of bulk material handling seems straightforward at first glance: moving, filling, delivering. However, the art of dealing with a variety of different ...

Flera cancerstudier dras tillbaka efter misstänkt fusk

I början av året påstod en bloggare att flera artiklar skrivna av forskare på cancerinstitutet Dana-Farber, som är kopplat till Harvard, innehöll felaktigheter....

RegFile AB

Sahlgrenska Science Park

LINK Medical Research

Eli Lilly värvar toppforskaren Kaj Blennow – ska leda Alzheimerprojekt

Eli Lilly rekryterar Kaj Blennow, en av Sveriges och världens främsta forskare inom Alzheimers sjukdom, till en post som Vice President of Neuroscience Biomarker Development.

Kompauto Nordic AB

Merck Life Science A/S

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm (2026)

Medhouse är med och lanserar GAPS - en global allians inom Life Science

Medhouse har tillsammans med 6 andra internationella konsultföretag skapat Global Alliance for Pharma Solutions (GAPS). Alliansen består därmed av ett robust in...

Medicon Village Science Park

Hypothesis testing versus conspiracy theory

"How do you know what is a conspiracy theory and what is a reasonable, scientifically based conclusion?" In a column, Ingrid Lönnstedt reflects on this question.

Bio-Works

Trends and overview: ELRIG "Robotics and Automation"

Laboratories on the way to end-to-end automation: Robotics, artificial intelligence and automation technology boosted by pandemic

Large study on milk: Risky for women but not for men

The risk of ischemic heart disease (IHD) and acute myocardial infarction (MI) increased for women with milk intake levels higher than 2 glasses per day, while n...

Xbrane enters licensing agreement with Indian generics giant

Swedish biosimilar developer Xbrane Biopharma and the Indian company Intas Pharmaceuticals have entered into a license and co-development agreement.

Novo Nordisk to invest billions in new quality control lab

Novo Nordisk has announced plans to invest 2.9 billion Danish kroner in order to establish a new quality control laboratory in Hillerød in northern Zealand, Denmark.

New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...

Ny mjukvara ger dig full koll på dina massflödesprodukter

Håll koll på flödet med Windows-baserad mjukvara från Brooks.

Festo AB

Quotient Sciences Limited

600 million SEK for life science - "Should not be the country of moderation"

Sweden will prioritize excellence over breadth in research. This was made clear when the government presented the research proposition for the next four years.